1)  takeover
控股权转移
1.
Based on an overall sample ever so far, this paper gives a general picture of the corporate takeover cases taking place from 1993 to 2002.
本文以迄今为止最完整的样本考察了1993年至2002年上市公司控股权转移的基本情况和交易特征。
2)  holding shares
控股
1.
In recent years, the number of enterprises solely owned by foreign businessmen increasing faster, the investment forms of foreign businessmen in China are changing from pool capital to holding shares, then to exclusive investment in structure.
近几年来 ,外商独资企业数量增加较快 ,外商在华投资方式正在发生从合资到控股到独资结构性变化。
3)  holding share
控股
1.
In joint ventures operations, Chinese side usually wants to control its interests by holding shares of the company.
在中外合资经营中 ,中方为保障其利益往往设想通过控股而控制利益 ,而在实际操作中这种想法往往会落空。
4)  state-holding
国有控股
1.
After the state civil aviation transportation corporations of our country are recomposed,several state-holding civil aviation transportation corporations with china airline,southern airline and eastern airline group taking the head,come into existence,and the modern civil aviation transportation corporation system is preliminary founded.
中国国有航空运输企业进行重组后,形成了以中航、南航、东航集团为首的国有航空运输集团公司,初步建立了国有控股的航空运输企业的现代企业制度。
5)  controlling shareholder
控股股东
1.
The Endogenesis of Ownership Structure:Evidence Form Controlling Shareholder s Internal Capital Market in China;
股权结构的内生性:从我国基于控股股东的内部资本市场得到的证据
2.
Study on the Agency Problem of Controlling Shareholder in China's Listed Companies;
中国上市公司控股股东的代理问题研究
3.
An Empirical Study of the Relationship between Controlling Shareholder and Accounting Earnings Quality;
控股股东与盈余质量关系的实证研究
6)  holding company
控股公司
1.
Discussion about the Organization of a Financial Department within a State - owened Holding Company;
国有控股公司财务部门组织结构探讨
2.
On Risk and Rate of Return of Holding Company;
论控股公司的风险与回报率
3.
An examination of the nature and functions of state owned pure industrial holding company;
试论国有纯粹型产业控股公司的特性及功能
参考词条
补充资料:正常人白细胞转移因子 , 白细胞转移因子,转移因子
药物名称:转移因子

英文名:Transfer Factor

别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名:Transfer Factor ,TF
适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。
用量用法:
一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。
规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000.
注:严禁静脉给药.



类别:免疫调节剂
说明:补充资料仅用于学习参考,请勿用于其它任何用途。